1. Home
  2. ULCC vs MLTX Comparison

ULCC vs MLTX Comparison

Compare ULCC & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Frontier Group Holdings Inc.

ULCC

Frontier Group Holdings Inc.

HOLD

Current Price

$5.36

Market Cap

1.2B

ML Signal

HOLD

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

HOLD

Current Price

$15.80

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ULCC
MLTX
Founded
1994
2021
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
ULCC
MLTX
Price
$5.36
$15.80
Analyst Decision
Hold
Buy
Analyst Count
10
9
Target Price
$5.67
$22.22
AVG Volume (30 Days)
3.7M
1.2M
Earning Date
02-11-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,724,000,000.00
N/A
Revenue This Year
$18.37
N/A
Revenue Next Year
$12.30
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.89
$5.95
52 Week High
$9.58
$62.75

Technical Indicators

Market Signals
Indicator
ULCC
MLTX
Relative Strength Index (RSI) 50.12 52.61
Support Level $4.93 $15.27
Resistance Level $6.49 $16.15
Average True Range (ATR) 0.50 0.74
MACD -0.01 -0.09
Stochastic Oscillator 35.47 58.69

Price Performance

Historical Comparison
ULCC
MLTX

About ULCC Frontier Group Holdings Inc.

Frontier Group Holdings Inc is an ultra-low-cost carrier whose business is focused on Low Fares Done Right. The company owns a fleet of 120 Airbus single-aisle aircraft, consisting of 13 A320ceos, 82 A320neos, 21 A321ceos and 4 A321neos. The use of these aircraft, their seating configuration, weight-saving tactics, and baggage process have all contributed to the ability to continue to be the fuel-efficient of all the U.S. The Company is managed as a single business unit that provides air transportation for passengers. Majority of revenue is from Domestic flight follow by International.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

Share on Social Networks: